Literature DB >> 20610797

Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs.

Taija E Pietilä1, Sinikka Latvala, Pamela Osterlund, Ilkka Julkunen.   

Abstract

Type I IFNs (IFN-α/βs) and type III IFNs (IFN-λ1-3) play an important role in host defense against viral infections. The induction of type I IFNs has recently been found to take place also in bacterial infections, and therefore, this study focuses on analyzing the regulation of type III IFNs in response to bacterial stimulation. We found by quantitative RT-PCR that the expression of IFN-λ1 and IFN-λ2/3 mRNAs, as well as that of IFN-β, was similarly up-regulated in response to stimulation with live Salmonella typhimurium or TLR4 agonist LPS in human moDCs. The induction of IFN-λ mRNAs did not require ongoing protein synthesis, and only IFN-λ1 was detected at the protein level. The induction of IFN-λ mRNAs was sensitive to SB202190, Ly294002, and PDTC, which inhibit p38 MAPK, PI3K, and NF-κB activation, respectively. Furthermore, we observed that blocking dynamin-dependent endocytosis pathways with dynasore led to decreased cell surface expression of CD86 and HLA class II molecules and reduced production of IFN-λ1, CXCL10, and IL-6 when the cells were infected with S. typhimurium. Cytokine production was also impaired in dynasore-treated, Streptococcus thermophilus-stimulated cells. Further, inhibition of dynamin prevented S. typhimurium-induced phosphorylation of IRF3 and the internalization of the bacteria. In summary, induction of type III IFNs in bacteria-infected human moDCs requires multiple signaling pathways and involves bacterial phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610797     DOI: 10.1189/jlb.1009651

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

1.  Mechanisms of Horizontal Cell-to-Cell Transfer of Wolbachia spp. in Drosophila melanogaster.

Authors:  Pamela M White; Jose E Pietri; Alain Debec; Shelbi Russell; Bhavin Patel; William Sullivan
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

Review 2.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression.

Authors:  Sanna M Mäkelä; Pamela Österlund; Veera Westenius; Sinikka Latvala; Michael S Diamond; Michael Gale; Ilkka Julkunen
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

4.  Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages.

Authors:  Minja Miettinen; Taija E Pietilä; Riina A Kekkonen; Matti Kankainen; Sinikka Latvala; Jaana Pirhonen; Pamela Österlund; Riitta Korpela; Ilkka Julkunen
Journal:  Gut Microbes       Date:  2012-08-16

Review 5.  Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis.

Authors:  Ayman El-Sayed; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

6.  Dynamin inhibition interferes with inflammasome activation and cytokine gene expression in Streptococcus pyogenes-infected human macrophages.

Authors:  S Latvala; S M Mäkelä; M Miettinen; E Charpentier; I Julkunen
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

7.  Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines.

Authors:  Andrea C Love; Ira Schwartz; Mary M Petzke
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

8.  Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.

Authors:  Hélène Bierne; Laetitia Travier; Tanel Mahlakõiv; Ludovic Tailleux; Agathe Subtil; Alice Lebreton; Anupam Paliwal; Brigitte Gicquel; Peter Staeheli; Marc Lecuit; Pascale Cossart
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 9.  Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.

Authors:  Helen M Lazear; Timothy J Nice; Michael S Diamond
Journal:  Immunity       Date:  2015-07-21       Impact factor: 31.745

Review 10.  The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons.

Authors:  Olivier Dussurget; Hélène Bierne; Pascale Cossart
Journal:  Front Cell Infect Microbiol       Date:  2014-04-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.